Drug Induced Movement Disorders

The second revised edition of this text will update and present current state of the art clinical approaches to this subject. This book will continue to be the source text of information on drug-induced movement disorders authored and edited by the pioneers in the field. It will be an invaluable addition to the library of any neurologist.

Dr. Stewart Factor, DO. Professor of Neurology, Riley Family Chair in Parkinson's Disease, Director, Parkinson's Disease and Movement Disorder Program, Albany Medical Center

Dr. Anthony E. Lang, MD. Movement Disorder Clinic, Toronto Western Hospital

Dr. William J. Weiner, MD. Chair, Department of Neurology, University of Maryland School of Medicine

List of contributors,

vii

Acknowledgements,

ix

Foreword,

x

Preface,

xiii

Part 1 General considerations

1 Movement disorders: an overview,

3

(17)

Martin Cloutier, Anthony E. Lang

2 Rating scales for movement disorders,

20

(10)

Ikwunga Wonodi, Elliot L. Hong, Matthew T. Avila, Gunvant K. Thaker

3 Spontaneous movement disorders in psychiatric patients,

30

(25)

Irene Richard, Christopher O'Brien, Roger Kurlan

Part 2 Antipsychotics

4 The pharmacology of typical and atypical antipsychotics,

55

(17)

Gary Remington, Shitij Kapur

5 Acute drug-induced dystonia,

72

(31)

Michael F. Mazurek, Patricia I. Rosebush

6 Drug-induced parkinsonism,

103

(37)

Joseph H. Friedman, Martha E. Trieschmann, Hubert H. Fernandez

7 Acute drug-induced akathisia,

140

(34)

Lenard A. Adler, John Rotrosen, Burt Angrist

8 Neuroleptic malignant syndrome,

174

(39)

Stewart A. Factor

9 Tardive dyskinesia,

213

(44)

Thomas M. Hyde, Jose A. Apud, Whitney C. Fisher, Michael F. Egan

10 Neuroleptic-induced tardive dyskinesia variants,

257

(28)

Frank Skidmore, William J. Weiner, Robert Burke

11 Movement disorders due to atypical antipsychotics,

285

(17)

Karen E. Anderson

12 Commentary: is tardive dyskinesia disappearing?,

302

(11)

James B. Lohr

Part 3 Dopaminomimetic drugs

13 Dyskinesia induced by levodopa and dopamine agonists in patients with Parkinson's disease,

313

(38)

John G. Nutt, Matthew A. Brodsky

14 Movement disorders and dopaminomimetic stimulant drugs,

351

(22)

Anthony E. Munson, Juan Sanchez-Ramos, William J. Weiner

Part 4 Other drugs

15 Antidepressants,

373

(35)

Maria L. Moro-de-Casillas, David E. Riley

16 Antiepileptics,

408

(22)

John C. Morgan, Madaline B. Harrison

17 Miscellaneous drug-induced movement disorders,

430

(12)

Daniel Tarsy

Index,

442

What is included with this book?

The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.

The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.

FREE SHIPPING

Amazon no longer offers textbook rentals. We do!

Drug Induced Movement Disorders

Summary

Author Biography

Table of Contents

Supplemental Materials